img

Global Genetic Disorders Drug Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application


Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Genetic Disorders Drug Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application

Genetic Disorders Drugs are genetic materials such as DNA and RNA delivered into the body as a therapeutic. They are a promising new class of medicine that was not possible even a short time ago.
Genetic Disorders Drug report published by Mr Accuracy reports reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Genetic Disorders Drug market is projected to reach US$ million in 2029, increasing from US$ million in 2022, with the CAGR of % during the period of 2024 to 2029. Demand from Clinic and Hospital are the major drivers for the industry.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Genetic Disorders Drug market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report



By Company


Sanofi
Vertex
Takeda
Amgen
GW Pharmaceuticals
Pfizer
BioMarin
Sarepta
Segment by Type
Cystic Fibrosis (CF)
Duchenne Muscular Dystrophy (DMD)
Lysosomal Storage Disease (LSD)
Paroxysmal Nocturnal Hemoglobinuria (PNH)

Segment by Application


Clinic
Hospital

Segment by Region


North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Each chapter of the report provides detailed information for readers to understand the Genetic Disorders Drug market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Genetic Disorders Drug, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Genetic Disorders Drug industry.
Chapter 3Historical (2018-2022) and forecast (2024-2034) volume and revenue analysis of Genetic Disorders Drug in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Genetic Disorders Drug introduction, etc. Genetic Disorders Drug Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13Mr Accuracy reports’s Conclusions of Genetic Disorders Drug market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by Mr Accuracy reports.

Table of Content

1 Genetic Disorders Drug Market Overview
1.1 Genetic Disorders Drug Product Overview
1.2 Genetic Disorders Drug Market Segment by Type
1.2.1 Cystic Fibrosis (CF)
1.2.2 Duchenne Muscular Dystrophy (DMD)
1.2.3 Lysosomal Storage Disease (LSD)
1.2.4 Paroxysmal Nocturnal Hemoglobinuria (PNH)
1.3 Global Genetic Disorders Drug Market Size by Type
1.3.1 Global Genetic Disorders Drug Market Size Overview by Type (2018-2029)
1.3.2 Global Genetic Disorders Drug Historic Market Size Review by Type (2018-2024)
1.3.3 Global Genetic Disorders Drug Forecasted Market Size by Type (2024-2029)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Genetic Disorders Drug Sales Breakdown by Type (2018-2024)
1.4.2 Europe Genetic Disorders Drug Sales Breakdown by Type (2018-2024)
1.4.3 Asia-Pacific Genetic Disorders Drug Sales Breakdown by Type (2018-2024)
1.4.4 Latin America Genetic Disorders Drug Sales Breakdown by Type (2018-2024)
1.4.5 Middle East and Africa Genetic Disorders Drug Sales Breakdown by Type (2018-2024)
2 Global Genetic Disorders Drug Market Competition by Company
2.1 Global Top Players by Genetic Disorders Drug Sales (2018-2024)
2.2 Global Top Players by Genetic Disorders Drug Revenue (2018-2024)
2.3 Global Top Players by Genetic Disorders Drug Price (2018-2024)
2.4 Global Top Manufacturers Genetic Disorders Drug Manufacturing Base Distribution, Sales Area, Product Type
2.5 Genetic Disorders Drug Market Competitive Situation and Trends
2.5.1 Genetic Disorders Drug Market Concentration Rate (2018-2024)
2.5.2 Global 5 and 10 Largest Manufacturers by Genetic Disorders Drug Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Genetic Disorders Drug as of 2022)
2.7 Date of Key Manufacturers Enter into Genetic Disorders Drug Market
2.8 Key Manufacturers Genetic Disorders Drug Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Genetic Disorders Drug Status and Outlook by Region
3.1 Global Genetic Disorders Drug Market Size and CAGR by Region: 2018 VS 2022 VS 2029
3.2 Global Genetic Disorders Drug Historic Market Size by Region
3.2.1 Global Genetic Disorders Drug Sales in Volume by Region (2018-2024)
3.2.2 Global Genetic Disorders Drug Sales in Value by Region (2018-2024)
3.2.3 Global Genetic Disorders Drug Sales (Volume & Value) Price and Gross Margin (2018-2024)
3.3 Global Genetic Disorders Drug Forecasted Market Size by Region
3.3.1 Global Genetic Disorders Drug Sales in Volume by Region (2024-2029)
3.3.2 Global Genetic Disorders Drug Sales in Value by Region (2024-2029)
3.3.3 Global Genetic Disorders Drug Sales (Volume & Value), Price and Gross Margin (2024-2029)
4 Global Genetic Disorders Drug by Application
4.1 Genetic Disorders Drug Market Segment by Application
4.1.1 Clinic
4.1.2 Hospital
4.2 Global Genetic Disorders Drug Market Size by Application
4.2.1 Global Genetic Disorders Drug Market Size Overview by Application (2018-2029)
4.2.2 Global Genetic Disorders Drug Historic Market Size Review by Application (2018-2024)
4.2.3 Global Genetic Disorders Drug Forecasted Market Size by Application (2024-2029)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Genetic Disorders Drug Sales Breakdown by Application (2018-2024)
4.3.2 Europe Genetic Disorders Drug Sales Breakdown by Application (2018-2024)
4.3.3 Asia-Pacific Genetic Disorders Drug Sales Breakdown by Application (2018-2024)
4.3.4 Latin America Genetic Disorders Drug Sales Breakdown by Application (2018-2024)
4.3.5 Middle East and Africa Genetic Disorders Drug Sales Breakdown by Application (2018-2024)
5 North America Genetic Disorders Drug by Country
5.1 North America Genetic Disorders Drug Historic Market Size by Country
5.1.1 North America Genetic Disorders Drug Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
5.1.2 North America Genetic Disorders Drug Sales in Volume by Country (2018-2024)
5.1.3 North America Genetic Disorders Drug Sales in Value by Country (2018-2024)
5.2 North America Genetic Disorders Drug Forecasted Market Size by Country
5.2.1 North America Genetic Disorders Drug Sales in Volume by Country (2024-2029)
5.2.2 North America Genetic Disorders Drug Sales in Value by Country (2024-2029)
6 Europe Genetic Disorders Drug by Country
6.1 Europe Genetic Disorders Drug Historic Market Size by Country
6.1.1 Europe Genetic Disorders Drug Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
6.1.2 Europe Genetic Disorders Drug Sales in Volume by Country (2018-2024)
6.1.3 Europe Genetic Disorders Drug Sales in Value by Country (2018-2024)
6.2 Europe Genetic Disorders Drug Forecasted Market Size by Country
6.2.1 Europe Genetic Disorders Drug Sales in Volume by Country (2024-2029)
6.2.2 Europe Genetic Disorders Drug Sales in Value by Country (2024-2029)
7 Asia-Pacific Genetic Disorders Drug by Region
7.1 Asia-Pacific Genetic Disorders Drug Historic Market Size by Region
7.1.1 Asia-Pacific Genetic Disorders Drug Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2029
7.1.2 Asia-Pacific Genetic Disorders Drug Sales in Volume by Region (2018-2024)
7.1.3 Asia-Pacific Genetic Disorders Drug Sales in Value by Region (2018-2024)
7.2 Asia-Pacific Genetic Disorders Drug Forecasted Market Size by Region
7.2.1 Asia-Pacific Genetic Disorders Drug Sales in Volume by Region (2024-2029)
7.2.2 Asia-Pacific Genetic Disorders Drug Sales in Value by Region (2024-2029)
8 Latin America Genetic Disorders Drug by Country
8.1 Latin America Genetic Disorders Drug Historic Market Size by Country
8.1.1 Latin America Genetic Disorders Drug Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
8.1.2 Latin America Genetic Disorders Drug Sales in Volume by Country (2018-2024)
8.1.3 Latin America Genetic Disorders Drug Sales in Value by Country (2018-2024)
8.2 Latin America Genetic Disorders Drug Forecasted Market Size by Country
8.2.1 Latin America Genetic Disorders Drug Sales in Volume by Country (2024-2029)
8.2.2 Latin America Genetic Disorders Drug Sales in Value by Country (2024-2029)
9 Middle East and Africa Genetic Disorders Drug by Country
9.1 Middle East and Africa Genetic Disorders Drug Historic Market Size by Country
9.1.1 Middle East and Africa Genetic Disorders Drug Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
9.1.2 Middle East and Africa Genetic Disorders Drug Sales in Volume by Country (2018-2024)
9.1.3 Middle East and Africa Genetic Disorders Drug Sales in Value by Country (2018-2024)
9.2 Middle East and Africa Genetic Disorders Drug Forecasted Market Size by Country
9.2.1 Middle East and Africa Genetic Disorders Drug Sales in Volume by Country (2024-2029)
9.2.2 Middle East and Africa Genetic Disorders Drug Sales in Value by Country (2024-2029)
10 Company Profiles
10.1 Sanofi
10.1.1 Sanofi Company Information
10.1.2 Sanofi Introduction and Business Overview
10.1.3 Sanofi Genetic Disorders Drug Sales, Revenue and Gross Margin (2018-2024)
10.1.4 Sanofi Genetic Disorders Drug Products Offered
10.1.5 Sanofi Recent Development
10.2 Vertex
10.2.1 Vertex Company Information
10.2.2 Vertex Introduction and Business Overview
10.2.3 Vertex Genetic Disorders Drug Sales, Revenue and Gross Margin (2018-2024)
10.2.4 Vertex Genetic Disorders Drug Products Offered
10.2.5 Vertex Recent Development
10.3 Takeda
10.3.1 Takeda Company Information
10.3.2 Takeda Introduction and Business Overview
10.3.3 Takeda Genetic Disorders Drug Sales, Revenue and Gross Margin (2018-2024)
10.3.4 Takeda Genetic Disorders Drug Products Offered
10.3.5 Takeda Recent Development
10.4 Amgen
10.4.1 Amgen Company Information
10.4.2 Amgen Introduction and Business Overview
10.4.3 Amgen Genetic Disorders Drug Sales, Revenue and Gross Margin (2018-2024)
10.4.4 Amgen Genetic Disorders Drug Products Offered
10.4.5 Amgen Recent Development
10.5 GW Pharmaceuticals
10.5.1 GW Pharmaceuticals Company Information
10.5.2 GW Pharmaceuticals Introduction and Business Overview
10.5.3 GW Pharmaceuticals Genetic Disorders Drug Sales, Revenue and Gross Margin (2018-2024)
10.5.4 GW Pharmaceuticals Genetic Disorders Drug Products Offered
10.5.5 GW Pharmaceuticals Recent Development
10.6 Pfizer
10.6.1 Pfizer Company Information
10.6.2 Pfizer Introduction and Business Overview
10.6.3 Pfizer Genetic Disorders Drug Sales, Revenue and Gross Margin (2018-2024)
10.6.4 Pfizer Genetic Disorders Drug Products Offered
10.6.5 Pfizer Recent Development
10.7 BioMarin
10.7.1 BioMarin Company Information
10.7.2 BioMarin Introduction and Business Overview
10.7.3 BioMarin Genetic Disorders Drug Sales, Revenue and Gross Margin (2018-2024)
10.7.4 BioMarin Genetic Disorders Drug Products Offered
10.7.5 BioMarin Recent Development
10.8 Sarepta
10.8.1 Sarepta Company Information
10.8.2 Sarepta Introduction and Business Overview
10.8.3 Sarepta Genetic Disorders Drug Sales, Revenue and Gross Margin (2018-2024)
10.8.4 Sarepta Genetic Disorders Drug Products Offered
10.8.5 Sarepta Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Genetic Disorders Drug Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Genetic Disorders Drug Industrial Chain Analysis
11.4 Genetic Disorders Drug Market Dynamics
11.4.1 Genetic Disorders Drug Industry Trends
11.4.2 Genetic Disorders Drug Market Drivers
11.4.3 Genetic Disorders Drug Market Challenges
11.4.4 Genetic Disorders Drug Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Genetic Disorders Drug Distributors
12.3 Genetic Disorders Drug Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer

List of Figure

List of Tables
Table 1. Major Company of Cystic Fibrosis (CF)
Table 2. Major Company of Duchenne Muscular Dystrophy (DMD)
Table 3. Major Company of Lysosomal Storage Disease (LSD)
Table 4. Major Company of Paroxysmal Nocturnal Hemoglobinuria (PNH)
Table 5. Global Genetic Disorders Drug Sales by Type 2018 VS 2022 VS 2029 (US$ Million)
Table 6. Global Genetic Disorders Drug Sales by Type (2018-2024) & (K Doses)
Table 7. Global Genetic Disorders Drug Sales Market Share in Volume by Type (2018-2024)
Table 8. Global Genetic Disorders Drug Sales by Type (2018-2024) & (US& Million)
Table 9. Global Genetic Disorders Drug Market Share in Value by Type (2018-2024)
Table 10. Global Genetic Disorders Drug Price by Type (2018-2024) & (USD/Dose)
Table 11. Global Genetic Disorders Drug Sales by Type (2024-2029) & (K Doses)
Table 12. Global Genetic Disorders Drug Sales Market Share in Volume by Type (2024-2029)
Table 13. Global Genetic Disorders Drug Sales by Type (2024-2029) & (US$ Million)
Table 14. Global Genetic Disorders Drug Sales Market Share in Value by Type (2024-2029)
Table 15. Global Genetic Disorders Drug Price by Type (2024-2029) & (USD/Dose)
Table 16. North America Genetic Disorders Drug Sales by Type (2018-2024) & (K Doses)
Table 17. North America Genetic Disorders Drug Sales by Type (2018-2024) & (US$ Million)
Table 18. Europe Genetic Disorders Drug Sales (K Doses) by Type (2018-2024)
Table 19. Europe Genetic Disorders Drug Sales by Type (2018-2024) & (US$ Million)
Table 20. Asia-Pacific Genetic Disorders Drug Sales (K Doses) by Type (2018-2024)
Table 21. Asia-Pacific Genetic Disorders Drug Sales by Type (2018-2024) & (US$ Million)
Table 22. Latin America Genetic Disorders Drug Sales (K Doses) by Type (2018-2024)
Table 23. Latin America Genetic Disorders Drug Sales by Type (2018-2024) & (US$ Million)
Table 24. Middle East and Africa Genetic Disorders Drug Sales (K Doses) by Type (2018-2024)
Table 25. Middle East and Africa Genetic Disorders Drug Sales by Type (2018-2024) & (US$ Million)
Table 26. Global Genetic Disorders Drug Sales by Company (2018-2024) & (K Doses)
Table 27. Global Genetic Disorders Drug Sales Share by Company (2018-2024)
Table 28. Global Genetic Disorders Drug Revenue by Company (2018-2024) & (US$ Million)
Table 29. Global Genetic Disorders Drug Revenue Share by Company (2018-2024)
Table 30. Global Market Genetic Disorders Drug Price by Company (2018-2024) & (USD/Dose)
Table 31. Global Genetic Disorders Drug Top Manufacturers Manufacturing Base Distribution and Sales Area
Table 32. Global Genetic Disorders Drug Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 33. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Genetic Disorders Drug as of 2022)
Table 34. Date of Key Manufacturers Enter into Genetic Disorders Drug Market
Table 35. Key Manufacturers Genetic Disorders Drug Product Type
Table 36. Mergers & Acquisitions, Expansion Plans
Table 37. Global Genetic Disorders Drug Market Size Comparison by Region (US$ Million): 2018 VS 2022 VS 2029
Table 38. Global Genetic Disorders Drug Sales by Region (2018-2024) & (K Doses)
Table 39. Global Genetic Disorders Drug Sales Market Share in Volume by Region (2018-2024)
Table 40. Global Genetic Disorders Drug Sales by Region (2018-2024) & (US$ Million)
Table 41. Global Genetic Disorders Drug Sales Market Share in Value by Region (2018-2024)
Table 42. Global Genetic Disorders Drug Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2018-2024)
Table 43. Global Genetic Disorders Drug Sales by Region (2024-2029) & (K Doses)
Table 44. Global Genetic Disorders Drug Sales Market Share in Volume by Region (2024-2029)
Table 45. Global Genetic Disorders Drug Sales by Region (2024-2029) & (US$ Million)
Table 46. Global Genetic Disorders Drug Sales Market Share in Value by Region (2024-2029)
Table 47. Global Genetic Disorders Drug Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2024-2029)
Table 48. Global Genetic Disorders Drug Sales by Application: 2018 VS 2022 VS 2029 (US$ Million)
Table 49. Global Genetic Disorders Drug Sales by Application (2018-2024) & (K Doses)
Table 50. Global Genetic Disorders Drug Sales Market Share in Volume by Application (2018-2024)
Table 51. Global Genetic Disorders Drug Sales by Application (2018-2024) & (US$ Million)
Table 52. Global Genetic Disorders Drug Sales Market Share in Value by Application (2018-2024)
Table 53. Global Genetic Disorders Drug Price by Application (2018-2024) & (USD/Dose)
Table 54. Global Genetic Disorders Drug Sales by Application (2024-2029) & (K Doses)
Table 55. Global Genetic Disorders Drug Sales Market Share in Volume by Application (2024-2029)
Table 56. Global Genetic Disorders Drug Sales by Application (2024-2029) & (US$ Million)
Table 57. Global Genetic Disorders Drug Sales Market Share in Value by Application (2024-2029)
Table 58. Global Genetic Disorders Drug Price by Application (2024-2029) & (USD/Dose)
Table 59. North America Genetic Disorders Drug Sales by Application (2018-2024) (K Doses)
Table 60. North America Genetic Disorders Drug Sales by Application (2018-2024) & (US$ Million)
Table 61. Europe Genetic Disorders Drug Sales by Application (2018-2024) (K Doses)
Table 62. Europe Genetic Disorders Drug Sales by Application (2018-2024) & (US$ Million)
Table 63. Asia-Pacific Genetic Disorders Drug Sales by Application (2018-2024) (K Doses)
Table 64. Asia-Pacific Genetic Disorders Drug Sales by Application (2018-2024) & (US$ Million)
Table 65. Latin America Genetic Disorders Drug Sales by Application (2018-2024) (K Doses)
Table 66. Latin America Genetic Disorders Drug Sales by Application (2018-2024) & (US$ Million)
Table 67. Middle East and Africa Genetic Disorders Drug Sales by Application (2018-2024) (K Doses)
Table 68. Middle East and Africa Genetic Disorders Drug Sales by Application (2018-2024) & (US$ Million)
Table 69. North America Genetic Disorders Drug Sales by Country (2018-2024) & (K Doses)
Table 70. North America Genetic Disorders Drug Sales Market Share in Volume by Country (2018-2024)
Table 71. North America Genetic Disorders Drug Sales by Country (2018-2024) & (US$ Million)
Table 72. North America Genetic Disorders Drug Sales Market Share in Value by Country (2018-2024)
Table 73. North America Genetic Disorders Drug Sales by Country (2024-2029) & (K Doses)
Table 74. North America Genetic Disorders Drug Sales Market Share in Volume by Country (2024-2029)
Table 75. North America Genetic Disorders Drug Sales by Country (2024-2029) & (US$ Million)
Table 76. North America Genetic Disorders Drug Sales Market Share in Value by Country (2024-2029)
Table 77. Europe Genetic Disorders Drug Sales by Country (2018-2024) & (K Doses)
Table 78. Europe Genetic Disorders Drug Sales Market Share in Volume by Country (2018-2024)
Table 79. Europe Genetic Disorders Drug Sales by Country (2018-2024) & (US$ Million)
Table 80. Europe Genetic Disorders Drug Sales Market Share in Value by Country (2018-2024)
Table 81. Europe Genetic Disorders Drug Sales by Country (2024-2029) & (K Doses)
Table 82. Europe Genetic Disorders Drug Sales Market Share in Volume by Country (2024-2029)
Table 83. Europe Genetic Disorders Drug Sales by Country (2024-2029) & (US$ Million)
Table 84. Europe Genetic Disorders Drug Sales Market Share in Value by Country (2024-2029)
Table 85. Asia-Pacific Genetic Disorders Drug Sales by Region (2018-2024) & (K Doses)
Table 86. Asia-Pacific Genetic Disorders Drug Sales Market Share in Volume by Region (2018-2024)
Table 87. Asia-Pacific Genetic Disorders Drug Sales by Region (2018-2024) & (US$ Million)
Table 88. Asia-Pacific Genetic Disorders Drug Sales Market Share in Value by Region (2018-2024)
Table 89. Asia-Pacific Genetic Disorders Drug Sales by Region (2024-2029) & (K Doses)
Table 90. Asia-Pacific Genetic Disorders Drug Sales Market Share in Volume by Region (2024-2029)
Table 91. Asia-Pacific Genetic Disorders Drug Sales by Region (2024-2029) & (US$ Million)
Table 92. Asia-Pacific Genetic Disorders Drug Sales Market Share in Value by Region (2024-2029)
Table 93. Latin America Genetic Disorders Drug Sales by Country (2018-2024) & (K Doses)
Table 94. Latin America Genetic Disorders Drug Sales Market Share in Volume by Country (2018-2024)
Table 95. Latin America Genetic Disorders Drug Sales by Country (2018-2024) & (US$ Million)
Table 96. Latin America Genetic Disorders Drug Sales Market Share in Value by Country (2018-2024)
Table 97. Latin America Genetic Disorders Drug Sales by Country (2024-2029) & (K Doses)
Table 98. Latin America Genetic Disorders Drug Sales Market Share in Volume by Country (2024-2029)
Table 99. Latin America Genetic Disorders Drug Sales by Country (2024-2029) & (US$ Million)
Table 100. Latin America Genetic Disorders Drug Sales Market Share in Value by Country (2024-2029)
Table 101. Middle East and Africa Genetic Disorders Drug Sales by Country (2018-2024) & (K Doses)
Table 102. Middle East and Africa Genetic Disorders Drug Sales Market Share in Volume by Country (2018-2024)
Table 103. Middle East and Africa Genetic Disorders Drug Sales by Country (2018-2024) & (US$ Million)
Table 104. Middle East and Africa Genetic Disorders Drug Sales Market Share in Value by Country (2018-2024)
Table 105. Middle East and Africa Genetic Disorders Drug Sales by Country (2024-2029) & (K Doses)
Table 106. Middle East and Africa Genetic Disorders Drug Sales Market Share in Volume by Country (2024-2029)
Table 107. Middle East and Africa Genetic Disorders Drug Sales by Country (2024-2029) & (US$ Million)
Table 108. Middle East and Africa Genetic Disorders Drug Sales Market Share in Value by Country (2024-2029)
Table 109. Sanofi Company Information
Table 110. Sanofi Introduction and Business Overview
Table 111. Sanofi Genetic Disorders Drug Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2018-2024)
Table 112. Sanofi Genetic Disorders Drug Product
Table 113. Sanofi Recent Development
Table 114. Vertex Company Information
Table 115. Vertex Introduction and Business Overview
Table 116. Vertex Genetic Disorders Drug Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2018-2024)
Table 117. Vertex Genetic Disorders Drug Product
Table 118. Vertex Recent Development
Table 119. Takeda Company Information
Table 120. Takeda Introduction and Business Overview
Table 121. Takeda Genetic Disorders Drug Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2018-2024)
Table 122. Takeda Genetic Disorders Drug Product
Table 123. Takeda Recent Development
Table 124. Amgen Company Information
Table 125. Amgen Introduction and Business Overview
Table 126. Amgen Genetic Disorders Drug Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2018-2024)
Table 127. Amgen Genetic Disorders Drug Product
Table 128. Amgen Recent Development
Table 129. GW Pharmaceuticals Company Information
Table 130. GW Pharmaceuticals Introduction and Business Overview
Table 131. GW Pharmaceuticals Genetic Disorders Drug Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2018-2024)
Table 132. GW Pharmaceuticals Genetic Disorders Drug Product
Table 133. GW Pharmaceuticals Recent Development
Table 134. Pfizer Company Information
Table 135. Pfizer Introduction and Business Overview
Table 136. Pfizer Genetic Disorders Drug Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2018-2024)
Table 137. Pfizer Genetic Disorders Drug Product
Table 138. Pfizer Recent Development
Table 139. BioMarin Company Information
Table 140. BioMarin Introduction and Business Overview
Table 141. BioMarin Genetic Disorders Drug Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2018-2024)
Table 142. BioMarin Genetic Disorders Drug Product
Table 143. BioMarin Recent Development
Table 144. Sarepta Company Information
Table 145. Sarepta Introduction and Business Overview
Table 146. Sarepta Genetic Disorders Drug Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2018-2024)
Table 147. Sarepta Genetic Disorders Drug Product
Table 148. Sarepta Recent Development
Table 149. Key Raw Materials Lists
Table 150. Raw Materials Key Suppliers Lists
Table 151. Genetic Disorders Drug Market Trends
Table 152. Genetic Disorders Drug Market Drivers
Table 153. Genetic Disorders Drug Market Challenges
Table 154. Genetic Disorders Drug Market Restraints
Table 155. Genetic Disorders Drug Distributors List
Table 156. Genetic Disorders Drug Downstream Customers
Table 157. Research Programs/Design for This Report
Table 158. Key Data Information from Secondary Sources
Table 159. Key Data Information from Primary Sources
List of Figures
Figure 1. Genetic Disorders Drug Product Picture
Figure 2. Global Genetic Disorders Drug Market Size, 2018 VS 2022 VS 2029 (US$ Million)
Figure 3. Global Genetic Disorders Drug Market Size Status and Outlook (2018-2029) & (US$ Million)
Figure 4. Global Genetic Disorders Drug Sales Status and Outlook (2018-2029) & (K Doses)
Figure 5. Product Picture of Cystic Fibrosis (CF)
Figure 6. Global Cystic Fibrosis (CF) Sales YoY Growth (2018-2029) & (K Doses)
Figure 7. Product Picture of Duchenne Muscular Dystrophy (DMD)
Figure 8. Global Duchenne Muscular Dystrophy (DMD) Sales YoY Growth (2018-2029) & (K Doses)
Figure 9. Product Picture of Lysosomal Storage Disease (LSD)
Figure 10. Global Lysosomal Storage Disease (LSD) Sales YoY Growth (2018-2029) & (K Doses)
Figure 11. Product Picture of Paroxysmal Nocturnal Hemoglobinuria (PNH)
Figure 12. Global Paroxysmal Nocturnal Hemoglobinuria (PNH) Sales YoY Growth (2018-2029) & (K Doses)
Figure 13. Global Genetic Disorders Drug Sales by Type (2018-2029) & (US$ Million)
Figure 14. Global Genetic Disorders Drug Sales Market Share by Type in 2022 & 2029
Figure 15. North America Genetic Disorders Drug Sales Market Share in Volume by Type in 2022
Figure 16. North America Genetic Disorders Drug Sales Market Share in Value by Type in 2022
Figure 17. Europe Genetic Disorders Drug Sales Market Share in Volume by Type in 2022
Figure 18. Europe Genetic Disorders Drug Sales Market Share in Value by Type in 2022
Figure 19. Asia-Pacific Genetic Disorders Drug Sales Market Share in Volume by Type in 2022
Figure 20. Asia-Pacific Genetic Disorders Drug Sales Market Share in Value by Type in 2022
Figure 21. Latin America Genetic Disorders Drug Sales Market Share in Volume by Type in 2022
Figure 22. Latin America Genetic Disorders Drug Sales Market Share in Value by Type in 2022
Figure 23. Middle East and Africa Genetic Disorders Drug Sales Market Share in Volume by Type in 2022
Figure 24. Middle East and Africa Genetic Disorders Drug Sales Market Share in Value by Type in 2022
Figure 25. The 5 and 10 Largest Manufacturers in the World: Market Share by Genetic Disorders Drug Sales in 2022
Figure 26. The 5 and 10 Largest Manufacturers in the World: Market Share by Genetic Disorders Drug Revenue in 2022
Figure 27. Genetic Disorders Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 28. Product Picture of Clinic
Figure 29. Global Clinic Sales YoY Growth (2018-2029) & (K Doses)
Figure 30. Product Picture of Hospital
Figure 31. Global Hospital Sales YoY Growth (2018-2029) & (K Doses)
Figure 32. Global Genetic Disorders Drug Sales by Application (2018-2029) & (US$ Million)
Figure 33. Global Genetic Disorders Drug Sales Market Share by Application in 2022 & 2029
Figure 34. North America Genetic Disorders Drug Sales Market Share in Volume by Application in 2022
Figure 35. North America Genetic Disorders Drug Sales Market Share in Value by Application in 2022
Figure 36. Europe Genetic Disorders Drug Sales Market Share in Volume by Application in 2022
Figure 37. Europe Genetic Disorders Drug Sales Market Share in Value by Application in 2022
Figure 38. Asia-Pacific Genetic Disorders Drug Sales Market Share in Volume by Application in 2022
Figure 39. Asia-Pacific Genetic Disorders Drug Sales Market Share in Value by Application in 2022
Figure 40. Latin America Genetic Disorders Drug Sales Market Share in Volume by Application in 2022
Figure 41. Latin America Genetic Disorders Drug Sales Market Share in Value by Application in 2022
Figure 42. Middle East and Africa Genetic Disorders Drug Sales Market Share in Value by Application in 2022
Figure 43. Key Raw Materials Price
Figure 44. Genetic Disorders Drug Manufacturing Cost Structure
Figure 45. Genetic Disorders Drug Industrial Chain Analysis
Figure 46. Channels of Distribution
Figure 47. Distributors Profiles
Figure 48. Bottom-up and Top-down Approaches for This Report
Figure 49. Data Triangulation
Figure 50. Key Executives Interviewed